Ece Özcan-Bülbül (Ece Özcan Bülbül)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis

Optical Coherence Tomography

Top Venues

Pharmaceutical development and technology

Pharmaceuticals (Basel, Switzerland)

Journal of drug targeting

AAPS PharmSciTech

This page only lists publications with an associated author ORCID identifier.

Publications

Ece Özcan-Bülbül, Yağmur Kalender, Ayça Bal-Öztürk, Neslihan Üstündağ Okur
Preparation and In Vitro Evaluation of Montelukast Sodium-Loaded 3D Printed Orodispersible Films for the Treatment of Asthma. AAPS PharmSciTech 25 (7) (2024)
Ayça Bal-Öztürk, Ece Özcan-Bülbül, Hazal Ezgi Gültekin, Berivan Cecen, Ebru Demir, Atefeh Zarepour, Sibel Cetinel, Ali Zarrabi
Application of Convergent Science and Technology toward Ocular Disease Treatment. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Ayça Bal-Öztürk, Ece Özcan-Bülbül, Hazal Ezgi Gültekin, Berivan Cecen, Ebru Demir, Atefeh Zarepour, Sibel Cetinel, Ali Zarrabi
Application of Convergent Science and Technology toward Ocular Disease Treatment. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Ayça Bal-Öztürk, Ece Özcan-Bülbül, Hazal Ezgi Gültekin, Berivan Cecen, Ebru Demir, Atefeh Zarepour, Sibel Cetinel, Ali Zarrabi
Application of Convergent Science and Technology toward Ocular Disease Treatment. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Panoraia I Siafaka, Ece Özcan-Bülbül, Mehmet Evren Okur, Ioannis D Karantas, Neslihan Üstündağ Okur
The Application of Nanogels as Efficient Drug Delivery Platforms for Dermal/Transdermal Delivery. Gels (Basel, Switzerland) 9 (9) (2023)
Al-Taie Anmar, Ece Özcan-Bülbül
A Paradigm Use of Monoclonal Antibodies-conjugated Nanoparticles in Breast Cancer Treatment: Current Status and Potential Approaches. Journal of drug targeting (2023)
Ece Özcan-Bülbül, Hasan Ali Husseın, Gizem Yeğen, Mehmet Evren Okur, Neslihan Üstündağ Okur, Neşe Buket Aksu
Preparation and in vitro-in vivo evaluation of QbD based acemetacin loaded transdermal patch formulations for rheumatic diseases. Pharmaceutical development and technology 27 (10) (2022)
Ece Özcan-Bülbül, Hasan Ali Husseın, Gizem Yeğen, Mehmet Evren Okur, Neslihan Üstündağ Okur, Neşe Buket Aksu
Preparation and in vitro-in vivo evaluation of QbD based acemetacin loaded transdermal patch formulations for rheumatic diseases. Pharmaceutical development and technology 27 (10) (2022)
Ece Özcan-Bülbül, Hasan Ali Husseın, Gizem Yeğen, Mehmet Evren Okur, Neslihan Üstündağ Okur, Neşe Buket Aksu
Preparation and in vitro-in vivo evaluation of QbD based acemetacin loaded transdermal patch formulations for rheumatic diseases. Pharmaceutical development and technology (2022)
Ece Özcan-Bülbül, Hasan Ali Husseın, Gizem Yeğen, Mehmet Evren Okur, Neslihan Üstündağ Okur, Neşe Buket Aksu
Preparation and in vitro-in vivo evaluation of QbD based acemetacin loaded transdermal patch formulations for rheumatic diseases. Pharmaceutical development and technology 27 (10) (2022)
Panoraia I Siafaka, Ece Özcan-Bülbül, Pelin Dilsiz, Ioannis D Karantas, Mehmet Evren Okur, Neslihan Üstündağ Okur
Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications. Journal of drug targeting 29 (5) (2021)